Apixaban Versus Enoxaparin in Elective Major Orthopedic Surgery-Reference-Cited by-同舟云学术

Apixaban Versus Enoxaparin in Elective Major Orthopedic Surgery

Published:2014-08-13 Issue:2 Volume:21 Page:115-119
ISSN:1076-0296
Container-title:Clinical and Applied Thrombosis/Hemostasis
language:en
Short-container-title:Clin Appl Thromb Hemost

Author:

Maniscalco Pietro¹,Caforio Marco¹,Imberti Davide²,Porcellini Giuseppe³,Benedetti Raffaella²

Affiliation:

1. Department of Orthopaedics and Traumatology, Piacenza Hospital, Piacenza, Italy

2. Department of Internal Medicine, Piacenza Hospital, Piacenza, Italy

3. Department of Orthopaedic Shoulder Surgery, Cattolica, Rimini, Italy

Abstract

Despite current guidelines recommendations about anticoagulant prophylaxis, many studies have shown an high venous thromboembolism (VTE) incidence in patients undergoing total hip and knee arthroplasty. A number of anticoagulants are currently available, but they have some limitations that affect their applicability and consequently their effectiveness. Several new oral anticoagulants (NOACs) have been developed in an attempt to overcome these limitations. Apixaban is a NOAC that selectively inhibits the coagulation factor Xa; it is approved for the prevention of VTE after total hip replacement and total knee replacement surgery. This review examines the results of main trials designed to test efficacy and safety of apixaban in major elective orthopedic surgery.

Publisher

SAGE Publications

Subject

Hematology,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/1076029614546328

Reference17 articles.

1. Prevention of VTE in patients having major orthopedic surgery

2. Prevention of VTE in Orthopedic Surgery Patients

3. Therapeutic potential of apixaban in the prevention of venous thromboembolism in patients undergoing total knee replacement surgery

4. Ximelagatran versus warfarin for prophylaxis of venous thromboembolism in major orthopedic surgery: systematic review of randomized controlled trials

5. A systematic review of rivaroxaban versus enoxaparin in the prevention of venous thromboembolism after hip or knee replacement

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombotic prophylaxis following total hip arthroplasty: a level I Bayesian network meta-analysis;Journal of Orthopaedics and Traumatology;2024-01-09

2. Effective VTE prophylaxis with enoxaparin after elective THR or TKR: a retrospective observational study;Porto Biomedical Journal;2023-07

3. Apixaban or enoxaparin: Which is better for thromboprophylaxis after total hip and total knee arthroplasty in Indian patients?;British Journal of Clinical Pharmacology;2021-07-13

4. Semiautomatic intermittent pneumatic compression device applied to deep vein thrombosis in major orthopedic surgery;BioMedical Engineering OnLine;2018-06-15

5. Preoperative Assessment of Colorectal Patients;The ASCRS Textbook of Colon and Rectal Surgery;2016